Search Within

Shari Goldfarb

  1. "Behavioral Sciences Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Behavioral Sciences Service (10)
  2. Breast Medicine Service (10)
  3. Department of Medicine (10)
  4. Epidemiology and Biostatistics (10)
  5. Health Outcomes Research Group (10)
  6. Population Sciences Research Program (10)

More Groups

People
  1. Clifford Hudis (7)
  2. Diana Lake (6)
  3. Gabriella D'Andrea-Carlino (6)
  4. Maura Dickler (6)
  5. Shanu Modi (6)
  6. Sujata Patil (6)

More People

Years
  1. 2024 (1)
  2. 2015 (3)
  3. 2014 (1)
  4. 2013 (1)
  5. 2012 (2)
  6. 2009 (2)
Publications
  1. Cancer Research (4)
  2. Journal of Clinical Oncology (2)
  3. Clinical Breast Cancer (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Supportive Care in Cancer (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (2)
  4. Oxford University Press (1)
  5. Springer Verlag (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients
    Journal Article

    Kraehenbuehl, L.; Kang, D.; Bang, A. S.; Ketosugbo, K. F.; Hay, J.; Patil, S.; Goldfarb, S.; Cho, J.; Lacouture, M. E.
    Supportive Care in Cancer (2024)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy
    Journal Article

    Damast, S.; Alektiar, K. M.; Goldfarb, S.; Eaton, A.; Patil, S.; Mosenkis, J.; Bennett, A.; Atkinson, T.; Jewell, E.; Leitao, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with breast cancer: Prevalence and severity
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Sit, L.; Fruscione, M.; Barz, T.; Atkinson, T.; Hudis, C.; Basch, E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes
    Journal Article

    Basch, E.; Jia, X.; Heller, G.; Barz, A.; Sit, L.; Fruscione, M.; Appawu, M.; Iasonos, A.; Atkinson, T.; Goldfarb, S.; more...
    JNCI: Journal of the National Cancer Institute (2009)

    Fulltext@MSK | Save